Denial Prevention

Twenty Thousand Denied Catheter Claims, One Reason Behind 99.7% of Them

A second quarter 2026 review in DME Jurisdictions A and D pulled 20,000 denied urological claims and found that almost all of them failed for the same thing: the beneficiary's medical records were not there. That is $32.8 million in billed charges lost to a file, not a clinical judgment. Here is what has to be in the record before a catheter or a sterile kit ships.

DF
DocuFindr Editorial
August 28, 2026 8 min read

Posted August 11, 2026: The DME MACs published a supplier reminder on urinary catheters after CMS highlighted an OIG report on improper Medicare payments for intermittent catheters and sterile catheter kits. The OIG found claims paid where documentation did not support eligibility for coude-tip catheters or sterile kits, and where refill, proof of delivery, or Standard Written Order requirements were not met. The same notice disclosed the Jurisdiction A and D denial review: 20,000 claims, 99.7% denied for missing beneficiary medical records, $32,863,603 in billed amount.

A denial reason that is not really a denial reason

“Missing beneficiary medical records” is the least interesting sentence on a remittance advice. It tells you nothing about the patient, the product, or the policy. It just means the reviewer asked for the chart and did not get one that supported the claim.

Which is why it is worth sitting with the number. Out of 20,000 denied urological claims sampled across two jurisdictions in a single quarter, roughly 19,940 came back for that reason. Not coude-tip eligibility. Not the 200-per-month ceiling. Not a coding error. The records.

Catheter supply is a high-volume, low-unit-cost, recurring business. A supplier might ship the same patient 120 catheters a month for six years. The economics only work if intake is fast, and fast intake is exactly the workflow that treats a physician's order as the whole file. The order arrives by fax, someone confirms the HCPCS code and the quantity, the shipment goes out, and the claim pays. Nobody opens the progress note, because nothing forces them to.

An order proves someone wrote a prescription. It does not prove the beneficiary has permanent urinary retention, and Medicare does not pay for the prescription.

That gap runs quiet for years and then surfaces all at once, because urological supplies are recurring. When a reviewer samples a patient, they are not sampling one claim. They are sampling every month that patient has been on service. A single unsupported file becomes a multi-year overpayment with an extrapolation attached.

99.7%Of 20,000 denied urological claims reviewed in JA and JD in Q2 2026, denied for missing beneficiary medical records
$32.8MBilled amount attached to that single review sample
200Monthly ceiling per code, and the combined ceiling for A4297 and A4353 together

What the record has to say before anything else

Urological supplies are not paid under the durable medical equipment benefit. They fall under the Prosthetic Device benefit at Section 1861(s)(8) of the Social Security Act, and that benefit has a threshold written into it: the beneficiary must have permanent impairment of urination. Permanent urinary retention or permanent urinary incontinence.

Permanence in this context does not mean a physician has to certify the condition will never improve. It means the impairment is expected to last a long and indefinite time. But it does have to appear in the treating practitioner's records, in their words, tied to a condition. “Neurogenic bladder secondary to T6 spinal cord injury, requires intermittent catheterization” clears the bar. “Cath supplies, 120/month” does not, no matter how legible the signature is.

There is a genuine piece of good news buried in the same policy. Once initial medical need is established, ongoing need for urological supplies is assumed. There is no recurring continued-medical-need document to chase, as long as the beneficiary keeps meeting the Prosthetic Device benefit. The burden is front-loaded. Get the initial file right and the recurring months carry themselves, which is precisely the opposite of how most intake teams allocate their attention.

Pick ten catheter patients at random and ask whether the chart proves permanent retention today.Not the order. The practitioner's note. If two of the ten cannot produce it, you have a recurring exposure measured in months of service, not in single claims.
Book an Assessment

Four doors into a sterile kit, and one of them opened wider this year

Sterile intermittent catheter kits (A4297 for hydrophilic, A4353 for the rest) are where the OIG found the eligibility failures. A kit is not an upgrade a patient can simply prefer. Medicare covers one kit per covered catheterization episode only when the beneficiary requires catheterization and meets at least one of four conditions:

The beneficiary resides in a nursing facility. The beneficiary is immunosuppressed. The beneficiary has radiologically documented vesico-ureteral reflux while on a program of intermittent catheterization. Or the beneficiary has had distinct, recurrent urinary tract infections twice in the 12 months before the kits started, while on a sterile intermittent catheterization program.

The immunosuppression door is the one that changed. For dates of service on or after January 1, 2026, the LCD lists a diagnosis of spinal cord injury at any level among the qualifying examples of immunosuppression. The reasoning is that spinal cord injury disrupts autonomic and immune function, not only motor and sensory function. In practice it means an SCI patient no longer has to accumulate two documented UTIs on non-kit catheters before qualifying for kits. The diagnosis, documented by the practitioner, is enough.

That is a real expansion of access, and it is also a new way to get a claim wrong. The qualifying condition still has to be in the practitioner's records. A supplier's intake form noting “SCI” is not the practitioner documenting SCI.

If you are using the UTI door, the definition is unusually specific

The two-UTI path is the most commonly used and the most commonly failed, because “UTI” in this policy is not the clinical shorthand. The record needs a urine culture with greater than 10,000 colony forming units of a urinary pathogen, and at least one concurrent sign, symptom, or laboratory finding from a closed list:

Fever, oral temperature above 38 °C (100.4 °F)
Systemic leukocytosis
Change in urinary urgency, frequency, or incontinence
New or increased autonomic dysreflexia (sweating, bradycardia, blood pressure elevation)
Physical signs of prostatitis, epididymitis, or orchitis
Increased muscle spasms
Pyuria, greater than 5 white blood cells per high-powered field

Two of those events. Both within the 12 months before kits started. Both while the beneficiary was on a sterile intermittent catheterization program using either A4295 or A4296 without sterile lubricant, or A4351 or A4352 with sterile lubricant A4332. A urologist's note reading “recurrent UTIs” is a summary of that evidence, not the evidence.

Culture result plus one listed finding, twice, dated, while on a documented catheterization program. Anything short of that is a clinical impression the reviewer will not accept.

Six codes, six different questions the file has to answer

CodeWhat it isWhat the record must produceWhere files failRisk
A4351
Straight tip, non-hydrophilic
One per covered catheterization episode, with a sterile lubricant packet (A4332)Practitioner records showing permanent urinary retention or incontinence, and that the beneficiary or caregiver can perform the procedureOrder on file, chart silent on permanence; quantity billed with no documented catheterization frequencyHigh
A4352
Coude (curved) tip
Same allowance as A4351Everything A4351 needs, plus a documented reason a straight-tip catheter cannot be usedCoude billed on patient or referral-source preference with nothing in the chart explaining the anatomical or clinical barrierHigh
A4295 / A4296
Hydrophilic straight / coude
Required coding for hydrophilic catheters for dates of service on or after January 1, 2026. No separate lubricant.A Standard Written Order that describes the item billed. A4296 also needs the straight-tip justification.Old SWO naming A4351, A4352 or A4353 explicitly. That order no longer describes the item and a new SWO is required.High
A4297 / A4353
Sterile kit with insertion supplies
One per covered episode, only when one of the four kit criteria is metPractitioner documentation of nursing facility residence, immunosuppression (including SCI at any level), radiologically documented vesico-ureteral reflux, or two qualifying UTIs in the prior 12 monthsKit shipped on preference; SCI noted only on the supplier's intake form; UTI history summarized instead of evidenced; components shipped separately and billed as a kitHigh
A4332
Sterile lubricant packet
One per episode, paired with A4351 or A4352Rides on the catheter determinationBilled alongside A4295 or A4296, where the coating already provides lubricationModerate
A4311–A4316, A4338–A4346
Indwelling catheters
One per month for routine maintenanceFor any additional change: a documented non-routine reason (accidental removal, malfunction, obstruction by encrustation or clot, or an established pattern of recurrent obstruction or infection)Extra changes billed with no note explaining them; specialty or all-silicone catheters billed with no documented need for that specific catheterModerate

One detail in that table costs more than it looks. A kit is a kit because the components arrive packaged together and sterile as a unit. If a supplier ships the catheter and the insertion supplies as separate components and bills A4297 or A4353, the claim is denied as not reasonable and necessary. The policy is explicit that separately provided components do not achieve the same sterility. That is a warehouse decision creating a coverage denial, and it will never look like a documentation problem on the remittance advice.

Through Dec 31, 2025

Hydrophilic billed as A4351–A4353

No separate hydrophilic codes. SCI patients needed two documented UTIs, or another criterion, to qualify for sterile kits.

Jan 1, 2026

A4295, A4296, A4297 take effect

Hydrophilic catheters move to their own codes. The same revision adds spinal cord injury at any level to the immunosuppression examples for kit coverage.

Q2 2026

JA and JD denial review

20,000 denied claims sampled. 99.7% attributed to missing beneficiary medical records. $32,863,603 in billed charges.

Aug 11, 2026

Supplier reminder published

DME MACs restate the OIG findings on coude eligibility, kit eligibility, refill, proof of delivery, and Standard Written Orders.

The three operational requirements the OIG named

Coverage criteria get the attention. The OIG findings named three requirements that have nothing to do with clinical eligibility and everything to do with whether the supplier's own paperwork exists.

Standard Written Order

The SWO has to describe the item being billed. This became a live issue on January 1, 2026. If a beneficiary's existing order lists A4351, A4352 or A4353 by code and you are now billing A4295, A4296 or A4297, that order no longer describes the item and a new SWO is required. If the existing order used a general description such as “hydrophilic catheter,” or a brand and model number, it still describes the item and no new order is needed. Whether your legacy orders name codes or describe products decides how much rework the code change created, and most suppliers have never sorted their order file that way.

Refill documentation

Recurring supplies need a documented refill request from the beneficiary or caregiver, made within the correct window before the next shipment, confirming remaining quantity and continued need. An automated ship cycle that runs on a calendar rather than on a contact is the single easiest finding for a reviewer to write up, because the absence of the record is the finding.

Proof of delivery

Delivery has to be documented in a form that ties the beneficiary, the item, the quantity, and the date together. Shipping confirmations that show a tracking number and a zip code do not, on their own, establish what was in the box.

None of these three require a physician. All three are entirely within the supplier's control, which is what makes them uncomfortable findings. There is nobody upstream to blame.

Quantity: the ceiling is not the order

The policy sets a usual maximum of 200 units per month for A4295, A4296, A4297, A4332, A4351, A4352 and A4353, and caps any combination of A4297 and A4353 at 200 total. Suppliers sometimes read 200 as an allowance. It is a limit above which the claim will be denied as not reasonable and necessary.

Underneath the ceiling, the coverage rule is one catheter per covered catheterization episode. So the quantity on the claim is a function of documented catheterization frequency, and that frequency has to come from the medical record. A patient catheterizing five times a day supports 150 a month. The same patient with nothing in the chart about frequency supports an argument, not a quantity.

Going above 200 is not prohibited. It requires the medical necessity for the greater quantity to be well documented in the beneficiary's medical record and available on request. That is a higher bar than the ceiling itself, and it is worth knowing which of your patients sit above it before someone else finds them.

The KX modifier is a statement, not a formatting step

Appending KX to a urological code attests that the statutory and reasonable-and-necessary requirements for that item have been met. Not that you believe they probably have been. That they have, and that the evidence is on file and producible on request.

When a category is denying at 99.7% for missing records, the arithmetic gets awkward. Every one of those claims almost certainly carried a KX. Suppliers that add KX by default at the charge-master level have automated an assertion they cannot substantiate, and that is the distinction between a denial problem and an enforcement problem. If the criteria are not met, the correct answers are GA with a properly executed ABN, or GZ without one.

Pre-shipment and pre-submission checklist for urological supplies

The practitioner's records state permanent urinary retention or permanent incontinence
In the treating practitioner's words, tied to a diagnosis, in the chart. Urological supplies sit under the Prosthetic Device benefit and this is the statutory threshold. An order alone does not establish it.
The chart documents that the beneficiary or a caregiver can perform intermittent catheterization
This is a stated coverage condition for intermittent catheterization, and it is routinely absent from files that otherwise look complete.
For a sterile kit, one of the four criteria is documented by the practitioner
Nursing facility residence, immunosuppression (spinal cord injury at any level now qualifies as an example), radiologically documented vesico-ureteral reflux, or two qualifying UTIs in the prior 12 months. Verify which door you are using and that the chart walks through it.
If the UTI door: two dated events, each with a culture above 10,000 CFU plus a listed finding
Both within the prior 12 months, both while the beneficiary was on a sterile intermittent catheterization program with A4295/A4296 without lubricant or A4351/A4352 with A4332. A narrative reference to recurrent infections is not sufficient.
For a coude tip (A4296, A4352), the chart explains why a straight tip will not work
The DME MACs called this out by name. Document the anatomical or clinical barrier, not the preference.
The Standard Written Order describes the item you are billing today
Orders that name A4351, A4352 or A4353 by code need to be replaced before billing A4295, A4296 or A4297. Orders using a general description or a brand and model number carry over.
Quantity matches a catheterization frequency documented in the medical record
One catheter per covered episode. 200 per month is the ceiling, and any combination of A4297 and A4353 shares that same 200. Above it, the medical necessity for the greater quantity must be documented and producible.
Kits ship as kits
If the components are provided separately rather than packaged together, A4297 and A4353 are denied as not reasonable and necessary. Confirm this at the warehouse level, not the billing level.
Refill request and proof of delivery are on file for the shipment being billed
Both were named in the OIG findings. Both are entirely within your control. A calendar-driven ship cycle without a documented beneficiary contact will not survive review.
KX reflects the file, and GA or GZ is used when it does not
KX attests that the evidence exists and can be produced. Treat a default KX at the charge-master level as a compliance exposure, not a billing convenience.

Three things worth doing this week

1. Sort your Standard Written Orders by how they describe the product

Two buckets: orders that name a HCPCS code, and orders that describe the item. Every hydrophilic patient in the first bucket needs a new SWO before their next claim. Every patient in the second bucket does not. This is a query, not a project, and it separates real rework from imagined rework in an afternoon.

2. Audit ten paid sterile kit files, not ten denied ones

Pull the practitioner records and identify which of the four criteria each patient qualifies under. Write it down. If you cannot name the door for two or three of the ten, that is your rate, and every recurring month for those patients carries it.

3. Reconcile billed quantity against documented catheterization frequency

Take your top 25 patients by monthly units and find the frequency statement in each chart. Any patient where the shipped quantity has no clinical basis in the record is a claim you would lose on review, regardless of whether it sits under 200.

The reason this category denies at 99.7% for one cause is that the cause is invisible until someone asks. Catheter claims pay smoothly for years on files that were never built to survive a request for records. The fix is not more scrutiny at the back end. It is deciding, at intake, that the chart has to answer the question before the box goes out.

DocuFindr reads the catheter file against the rule that decides it

We validate DME intake documents before delivery and before submission, against the coverage criteria, order requirements and modifier logic that determine the outcome. For urological supplies that means whether the practitioner's records establish permanent retention or incontinence, which of the four sterile kit criteria the chart actually supports, whether coude-tip justification is present, whether the Standard Written Order still describes the item after the January 2026 code change, whether the billed quantity matches a documented catheterization frequency, and whether refill and proof of delivery are on file for the shipment being billed. If you want to see how your current catheter census reads against all of that, we will walk through it with you.

#UrologicalSupplies#IntermittentCatheter#A4295#A4297#A4351#A4353#L33803#A52521#SterileCatheterKit#CoudeTip#ProofOfDelivery#RefillDocumentation#DMEBilling#DenialPrevention#IntakeAutomation#RCM#DocuFindr